{"id":"bnt162b2-2025-2026-formulation","rwe":[],"tags":[],"safety":{"drugInteractions":[{"drug":"Warfarin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aspirin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pain medications (e.g., ibuprofen, naproxen)","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Anticoagulants (e.g., heparin, enoxaparin)","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Antiplatelets (e.g., clopidogrel, ticagrelor)","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Thrombolytics (e.g., alteplase, tenecteplase)","action":"Avoid","effect":"Increased risk of bleeding"},{"drug":"Live vaccines","action":"Avoid","effect":"Reduced efficacy of vaccine"},{"drug":"Interferon-alpha","action":"Avoid","effect":"Reduced efficacy of vaccine"},{"drug":"Immunosuppressants (e.g., corticosteroids, cyclosporine)","action":"Monitor","effect":"Reduced efficacy of vaccine"},{"drug":"Cholinesterase inhibitors (e.g., rivastigmine, donepezil)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Beta blockers (e.g., atenolol, metoprolol)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Calcium channel blockers (e.g., amlodipine, verapamil)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Digoxin","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antiarrhythmics (e.g., amiodarone, sotalol)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antihistamines (e.g., diphenhydramine, fexofenadine)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Anticholinergics (e.g., atropine, scopolamine)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Muscle relaxants (e.g., cyclobenzaprine, carisoprodol)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Sedatives (e.g., diazepam, lorazepam)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Opioids (e.g., morphine, fentanyl)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Anesthetics (e.g., propofol, ketamine)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antipsychotics (e.g., haloperidol, risperidone)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antidepressants (e.g., fluoxetine, sertraline)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antiemetics (e.g., ondansetron, metoclopramide)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antihistamines (e.g., diphenhydramine, fexofenadine)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Anticholinergics (e.g., atropine, scopolamine)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Muscle relaxants (e.g., cyclobenzaprine, carisoprodol)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Sedatives (e.g., diazepam, lorazepam)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Opioids (e.g., morphine, fentanyl)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Anesthetics (e.g., propofol, ketamine)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antipsychotics (e.g., haloperidol, risperidone)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antidepressants (e.g., fluoxetine, sertraline)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antiemetics (e.g., ondansetron, metoclopramide)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antihistamines (e.g., diphenhydramine, fexofenadine)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Anticholinergics (e.g., atropine, scopolamine)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Muscle relaxants (e.g., cyclobenzaprine, carisoprodol)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Sedatives (e.g., diazepam, lorazepam)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Opioids (e.g., morphine, fentanyl)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Anesthetics (e.g., propofol, ketamine)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antipsychotics (e.g., haloperidol, risperidone)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antidepressants (e.g., fluoxetine, sertraline)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antiemetics (e.g., ondansetron, metoclopramide)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antihistamines (e.g., diphenhydramine, fexofenadine)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Anticholinergics (e.g., atropine, scopolamine)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Muscle relaxants (e.g., cyclobenzaprine, carisoprodol)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Sedatives (e.g., diazepam, lorazepam)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Opioids (e.g., morphine, fentanyl)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Anesthetics (e.g., propofol, ketamine)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antipsychotics (e.g., haloperidol, risperidone)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antidepressants (e.g., fluoxetine, sertraline)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antiemetics (e.g., ondansetron, metoclopramide)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antihistamines (e.g., diphenhydramine, fexofenadine)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Anticholinergics (e.g., atropine, scopolamine)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Muscle relaxants (e.g., cyclobenzaprine, carisoprodol)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Sedatives (e.g., diazepam, lorazepam)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Opioids (e.g., morphine, fentanyl)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Anesthetics (e.g., propofol, ketamine)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antipsychotics (e.g., haloperidol, risperidone)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antidepressants (e.g., fluoxetine, sertraline)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antiemetics (e.g., ondansetron, metoclopramide)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antihistamines (e.g., diphenhydramine, fexofenadine)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Anticholinergics (e.g., atropine, scopolamine)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Muscle relaxants (e.g., cyclobenzaprine, carisoprodol)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Sedatives (e.g., diazepam, lorazepam)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Opioids (e.g., morphine, fentanyl)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Anesthetics (e.g., propofol, ketamine)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antipsychotics (e.g., haloperidol, risperidone)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antidepressants (e.g., fluoxetine, sertraline)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antiemetics (e.g., ondansetron, metoclopramide)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antihistamines (e.g., diphenhydramine, fexofenadine)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Anticholinergics (e.g., atropine, scopolamine)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Muscle relaxants (e.g., cyclobenzaprine, carisoprodol)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Sedatives (e.g., diazepam, lorazepam)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Opioids (e.g., morphine, fentanyl)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Anesthetics (e.g., propofol, ketamine)","action":"Monitor","effect":"Increased risk of bradycardia"},{"drug":"Antipsychotics (e.g., haloperidol, risperidone)","action":"Monitor","effect":"Increased risk of bradycardia"}],"commonSideEffects":[],"contraindications":["Known history of a severe allergic reaction (e.g., anaphylaxis) to any component of COMIRNATY.","Individuals who had a severe allergic reaction (e.g., anaphylaxis) following a previous dose of a Pfizer-BioNTech COVID-19 vaccine.","Analyses of postmarketing data from use of authorized or approved mRNA COVID-19 vaccines, including COMIRNATY, have demonstrated increased risks of myocarditis and pericarditis, with onset of symptoms observed risk has been highest in males 12 years through 24 years of age.","Immunocompromised persons, including individuals receiving immunosuppressant therapy, may have a diminished immune response to COMIRNATY."],"specialPopulations":{"Pregnancy":"The American College of Obstetricians and Gynecologists (ACOG) provides recommendations for the use of COVID-19 vaccines in individuals who are pregnant (or may become pregnant) or lactating. ACOG recommends that all pregnant individuals receive the seasonally updated COVID-19 vaccine booster (any currently authorized COVID-19 vaccine) at any time during pregnancy; the available data support the benefits of vaccination in reducing pregnancy complications and outcomes. The Pfizer-BioNTech COVID-19 vaccine 2025-2026 Formula is available in 2 presentations for different age groups. ACIP and ACOG recommend COVID-19 vaccination in pregnant women. Evidence indicates that benefits of vaccination against COVID-19 outweigh the risks. The vaccine administered to a woman who is breast-feeding has any effects on breast-fed infant or milk production. ACIP and ACOG recommend COVID-19 vaccination in people who are breastfeeding.","Geriatric use":"The current Comirnaty2025-2026 Formula is FDA-labeled for use in individuals ≥65 years of age, or in individuals with certain underlying conditions.","Paediatric use":"The Pfizer-BioNTech COVID-19 vaccine 2025-2026 Formula is available in 2 presentations for different age groups. The current Comirnaty2025-2026 Formula is FDA-labeled for use in individuals ≥65 years of age, or in individuals with certain underlying conditions. Has been used in children 6 months through 4 years of age†[off-label]for active immunization to COVID-19 vaccine. IM Single 0.3 mL dose recommended by manufacturer for pediatric patients ≥5 years of age with at least one risk factor for COVID-19. IM injections.","Renal impairment":"text","Hepatic impairment":"text"}},"trials":["NCT07222384"],"aliases":[],"company":"Pfizer","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=bnt162b2-2025-2026-formulation","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-05-16T02:03:09.103375+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:41:01.667957+00:00"},"regulatory.eu":{"url":"","method":"api_direct","source":"European Medicines Agency","rawText":"","confidence":1,"sourceType":"ema_api","retrievedAt":"2026-04-19T23:40:49.524512+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=bnt162b2-2025-2026-formulation","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:41:02.505021+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL582440/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:41:02.985511+00:00"}},"allNames":"bnt162b2 (2025/2026 formulation)","offLabel":[],"timeline":[],"aiSummary":"The BNT162b2 (2025/2026 formulation) is a small molecule vaccine used to study COVID-19 and SARS-COV-2 Infection in clinical trials. It is being investigated in a Phase 3 study to assess its safety and tolerability in children 5 through 11 years of age who are at higher risk of severe COVID-19.","brandName":"BNT162b2 (2025/2026 formulation)","ecosystem":[],"isGeneric":true,"mechanism":{"target":"SARS-CoV-2 spike protein","novelty":"first-in-class","modality":"mRNA-based vaccine","drugClass":"vaccine","explanation":"","oneSentence":"","technicalDetail":"BNT162b2 uses a lipid nanoparticle (LNP) delivery system to introduce the mRNA into cells, where it is translated into the SARS-CoV-2 spike protein. The immune system recognizes the spike protein as foreign and mounts an immune response, providing protection against the virus. The vaccine has been shown to be safe and effective in clinical trials, with a strong immune response and minimal side effects."},"_companyIR":{"url":"https://www.pfizer.com/investors","revenueRefs":[],"pipelineRefs":[]},"commercial":{"annualCostUS":"$80,000/yr","genericStatus":"Generic — off-patent","currentRevenue":"$21.2B","peakSalesEstimate":"$21.2B"},"references":[{"id":1,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=bnt162b2-2025-2026-formulation","fields":["publications"],"source":"PubMed/NCBI"},{"id":2,"url":"https://www.ema.europa.eu/","fields":["regulatoryStatus"],"source":"European Medicines Agency (EMA)"},{"id":3,"url":"https://list.essentialmeds.org/","fields":["regulatoryStatus"],"source":"WHO Essential Medicines List"}],"_tgaChecked":true,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-05-16T02:03:09.103485+00:00","fieldsConflicting":0,"overallConfidence":0.95},"_whoChecked":true,"biosimilars":[],"competitors":[{"name":"Abrysvo","company":"Unknown","advantage":"Prevents respiratory syncytial virus (RSV) lower respiratory tract infection"},{"name":"ACAM","company":"Unknown","advantage":"Unknown"}],"genericName":"bnt162b2-2025-2026-formulation","indications":{"approved":[{"name":"COVID-19 prevention","regulator":"FDA"},{"name":"COVID-19 treatment","regulator":"FDA"}],"offLabel":[],"pipeline":[]},"_mhraChecked":true,"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07222384","phase":"PHASE3","title":"A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19","status":"ACTIVE_NOT_RECRUITING","sponsor":"BioNTech SE","isPivotal":false,"enrollment":343,"indication":"COVID-19, SARS-COV-2 Infection","completionDate":"2026-07-31","primaryEndpoint":""}],"_emaApprovals":[{"date":"","name":"BNT162b2 (2025/2026 formulation)","status":"Authorised","regulator":"EMA"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"_warningLetters":[{"date":"03/28/2023","subject":"11/07/2022\tTodos Medical Ltd aka Todos Medical USA Inc\tCenter for Food Safety and Applied Nutrition"},{"date":"03/27/2026","subject":"Feedback form"}],"crossReferences":{"chemblId":"CHEMBL582440"},"formularyStatus":[],"_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Immunology"],"biosimilarFilings":[],"recentPublications":[],"_drugWebsiteChecked":true,"_healthCanadaChecked":true,"companionDiagnostics":[],"_genericFilersChecked":true,"genericManufacturerList":[],"phase":"marketed","status":"active","companyName":"Pfizer","companyId":"pfizer","modality":"mRNA-based vaccine","firstApprovalDate":"","enrichmentLevel":3,"visitCount":10,"regulatoryByCountry":[{"country_code":"EU","regulator":"EMA","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"pricingByCountry":[{"country_code":"US","currency":"USD","price_amount":"80000.00","price_per":"year","price_type":"annual_list","annual_cost_usd":null,"reimbursement_status":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-05-16T02:03:09.103485+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}